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Approximately15%of patients with Cystic Fibrosis (CF) present with intestinal
obstruction in immediatiate postnatal period secondary to ispissation of tenacious
meconium in the ileum. This is characteristic ﬁnding: we report a case CF newborn
presenting “apple peel atresia”.
C. was a 1910 g male infant born after 32 week twin pregnancy. His fetal ultrasound
showed bowel obstruction. He had bilious vomiting at birth: at surgery jejunum
atresia type IV with distal ileal loop wraping an Anomalous Mesenteric Axis (Apple
Peel Disease) were found. Resection of about 20 cm of distal loop and 5 cm of
proximal loop was performed. A second operation was necessary for a perforation
in an ectasic loop, seven days after. The child presented early onset of cholestasis
and Rx, at 21 day of age, showed lobar atelectasis of right upper lobe. Analysis
of speciﬁc mutations showed the presence of F508del and 541delC; sweat test was
abnormal: Cl 96mEq/L. Neonatal serum trypsine (IRT) level was normal. The other
two brothers had normal sweat test.
The term Apple Peel atresia describes a particular type of intestinal atresia
charachterized by an occlusion of the jejunum, reabsorption of the mesentery
and a wrapping of a large part of the small intestine around a thin vascular stalk
consisting of the left branch of the ileocolic artery. Although 10−15% of infants
with jejunoileal atresia are know to have CF, Apple Peel disease has reported in
association with Cf only in two cases.
In this report we point out the strict association between Cf and Apple Peel disease
and underline, as reported for meconium ileus, normal values of IRT at birth,
suggesting that also in this intestinal features, sweat test should be performed.
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Sweat test analysis were evaluated from suspected population of Ege Region of
Turkey and CF mutation analysis performed from cases with high sweat test results.
Sweat test was expressed as mmol/L (equivalent NaCl)conductivity. 1904 patients
were included in the study, sweat test results of 31 patients were found to be
higher than 80mmol/L NaCl conductivity and 16 patients’ test results were between
60−80mmol/L. 53 patients were undergone to CF mutation analysis. 2183AA>A,
2789 + 5G>A, G542X, N1303K, W1282, R347P, DF508 mutations were seen
frequently in all those patients. No mutations were detected in some of them
although with very high sweat test results. Surprisingly, DF508 mutation was not
the most common mutation as it was considered to be. There was a signiﬁcant
negative correlation between sweat test result and body mass index with an F value
of 0.026. Borderline cases were seen in adults, a very frequent circumstance in
normal adult populations of both sexes and two of them were the fathers of CF
diagnosed patients.
Normal adult values, though very frequently falling into the borderline range for
children, never reached the abnormal level. In fact, there is no borderline area for
adults. However, if an adult has a frankly CF sweat conductivity level, conﬁrmed
by repeat sweat tests, they must be considered positive. The results also show that
the body mass index could be a very useful marker for borderline cases. It was
abnormally low in CF subjects. Therefore, it might be valuable in the exclusion of
CF in cases with no mutations detected.
